A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

NCT01018173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2118

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: placebo
DRUG: taspoglutide

Sponsor

Hoffmann-La Roche